RegeneRx Biopharmaceutica Profile

USD 0.0025  0.74%
0.28Last Month High 0.34 
0.33Trading Day  High 0.34 

Acquisition or disposition of RegeneRx Biopharmaceutica securities by Sinaf Sa

RegeneRx Biopharmaceuticals Inc insider trading alert for acquisition or disposition of common stock warrant (right to buy) by Sinaf Sa, the corporate stakeholder, on October 17, 2017. This event was filed by Regenerx Biopharmaceutica with SEC on 2017-10-17. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

RegeneRx Biopharmaceutica Summary

RegeneRx Biopharmaceuticals Inc (RGRX) is traded on OTC Market in USA. It is located in RegeneRx Biopharmaceuticals, Inc.Rockville, MD and employs 3 people. The company currently falls under 'Micro-Cap' category with current market capitalization of 35.27 M. RegeneRx Biopharmaceuticals Inc has 106.88 M outstanding shares of which 43 K shares are at this time shorted by private and institutional investors with about 0.15 trading days to cover. REGENERX BIOPHARM currently holds about 243.16 K in cash with (1.38 M) of positive cash flow from operations.
Check RegeneRx Biopharmaceutica Probability Of Bankruptcy

Ownership Allocation (%)

RegeneRx Biopharmaceutica Risk Profiles

Key Fundamentals

RegeneRx Biopharmaceutica Against Markets

Current Ratings  

RegeneRx Biopharmaceutica 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
Chance of
< 45% 
RegeneRx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of therapeutic peptide, Thymosin beta 4, for tissue and organ protection, repair, and regeneration. more
NameRegeneRx Biopharmaceuticals Inc
Analyst Consensus
Macroaxis Advice
InstrumentUSA Stock Stocks Directory
Business AddressRegeneRx Biopharmaceuticals, Inc.Rockville, MD
ExchangeOTC Market
Contact Number301 208 9191
CurrencyUSD - US Dollar

Did you try this?

Run Analyst Recommendations Now

Analyst Recommendations

Analyst recommendations and target price estimates broken down by several categories
Hide  View All  Next  Launch Analyst Recommendations


RegeneRx Biopharmaceutica Analyst Recommendations
Target PriceAdvice# of Analysts
2.0Strong Buy1Odds
RegeneRx Biopharmaceuticals Inc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
RegeneRx Biopharmaceutica Analyst Advice  


Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  


RegeneRx Biopharmaceutica Earnings Estimates
EPSEstimate Date
Quarterly Estimate0.0April 10, 2017
RegeneRx Biopharmaceuticals Inc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate